Overview
Maris Sperga practices in Riga, Latvia. Sperga is rated as an Experienced expert by MediFind in the treatment of Insulinoma. Their top areas of expertise are Chromophobe Renal Cell Carcinoma, Renal Oncocytoma, Renal Cell Carcinoma (RCC), and Uterine Fibroids.
Their clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Insulinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chromophobe Renal Cell CarcinomaSperga isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Advanced
- Renal Cell Carcinoma (RCC)
- Renal OncocytomaSperga isAdvanced. Learn about Renal Oncocytoma.
- Experienced
- Actinic KeratosisSperga isExperienced. Learn about Actinic Keratosis.
- InsulinomaSperga isExperienced. Learn about Insulinoma.
- Neuroendocrine TumorSperga isExperienced. Learn about Neuroendocrine Tumor.
- Pancreatic Islet Cell TumorSperga isExperienced. Learn about Pancreatic Islet Cell Tumor.
- Squamous Cell Skin CarcinomaSperga isExperienced. Learn about Squamous Cell Skin Carcinoma.
- Uterine FibroidsSperga isExperienced. Learn about Uterine Fibroids.